These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8912368)

  • 1. Imaging technologies for radionuclide dosimetry.
    Ott RJ
    Phys Med Biol; 1996 Oct; 41(10):1885-94. PubMed ID: 8912368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of MINERVA Monte Carlo simulations to targeted radionuclide therapy.
    Descalle MA; Hartmann Siantar CL; Dauffy L; Nigg DW; Wemple CA; Yuan A; DeNardo GL
    Cancer Biother Radiopharm; 2003 Feb; 18(1):71-9. PubMed ID: 12667310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment planning for radio-immunotherapy.
    Erdi AK; Erdi YE; Yorke ED; Wessels BW
    Phys Med Biol; 1996 Oct; 41(10):2009-26. PubMed ID: 8912377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific basis of personalised tomographic radiation planning for radioembolisation: A form of brachytherapy planning.
    Kao YH; Goodwin M; Lee ST; Lichtenstein M; Scott AM
    J Med Imaging Radiat Oncol; 2015 Oct; 59(5):617-8. PubMed ID: 26238772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation and evaluation of patient-specific three-dimensional internal dosimetry.
    Kolbert KS; Sgouros G; Scott AM; Bronstein JE; Malane RA; Zhang J; Kalaigian H; McNamara S; Schwartz L; Larson SM
    J Nucl Med; 1997 Feb; 38(2):301-8. PubMed ID: 9025759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
    Ljungberg M; Celler A; Konijnenberg MW; Eckerman KF; Dewaraja YK; Sjögreen-Gleisner K; ; Bolch WE; Brill AB; Fahey F; Fisher DR; Hobbs R; Howell RW; Meredith RF; Sgouros G; Zanzonico P; ; Bacher K; Chiesa C; Flux G; Lassmann M; Strigari L; Walrand S
    J Nucl Med; 2016 Jan; 57(1):151-62. PubMed ID: 26471692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapy.
    Dewaraja YK; Frey EC; Sgouros G; Brill AB; Roberson P; Zanzonico PB; Ljungberg M
    J Nucl Med; 2012 Aug; 53(8):1310-25. PubMed ID: 22743252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted radionuclide therapy.
    Williams LE; DeNardo GL; Meredith RF
    Med Phys; 2008 Jul; 35(7):3062-8. PubMed ID: 18697529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?
    Bardiès M; Buvat I
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):5-20. PubMed ID: 21386782
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.
    Britton KE
    Acta Oncol; 1996; 35(3):385-90. PubMed ID: 8679271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.
    Dewaraja YK; Wilderman SJ; Ljungberg M; Koral KF; Zasadny K; Kaminiski MS
    J Nucl Med; 2005 May; 46(5):840-9. PubMed ID: 15872359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological imaging in clinical oncology: radiation therapy based on functional imaging.
    Lai YL; Wu CY; Chao KSC
    Int J Clin Oncol; 2016 Aug; 21(4):626-632. PubMed ID: 27384183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative imaging of (124)I with PET/ CT in pretherapy lesion dosimetry. Effects impairing image quantification and their corrections.
    Jentzen W; Freudenberg L; Bockisch A
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):21-43. PubMed ID: 21386783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (90)Y-PET/CT Imaging Quantification for Dosimetry in Peptide Receptor Radionuclide Therapy: Analysis and Corrections of the Impairing Factors.
    Fabbri C; Bartolomei M; Mattone V; Casi M; De Lauro F; Bartolini N; Gentili G; Amadori S; Agostini M; Sarti G
    Cancer Biother Radiopharm; 2015 Jun; 30(5):200-10. PubMed ID: 25860616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional radiobiologic dosimetry: application of radiobiologic modeling to patient-specific 3-dimensional imaging-based internal dosimetry.
    Prideaux AR; Song H; Hobbs RF; He B; Frey EC; Ladenson PW; Wahl RL; Sgouros G
    J Nucl Med; 2007 Jun; 48(6):1008-16. PubMed ID: 17504874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radionuclides and radiopharmaceuticals for single-photon emission tomography, positron emission tomography and radiotherapy in Russia.
    Krasikova RN; Kodina GE
    Eur J Nucl Med; 1999 Jul; 26(7):774-88. PubMed ID: 10398826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional imaging-based radiobiological dosimetry.
    Sgouros G; Frey E; Wahl R; He B; Prideaux A; Hobbs R
    Semin Nucl Med; 2008 Sep; 38(5):321-34. PubMed ID: 18662554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dosimetry for radionuclide therapy in a nonmyeloablative strategy.
    DeNardo GL; Siantar CL; DeNardo SJ
    Cancer Biother Radiopharm; 2002 Feb; 17(1):107-18. PubMed ID: 11915167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of fusion in radiotherapy treatment planning.
    Paulino AC; Thorstad WL; Fox T
    Semin Nucl Med; 2003 Jul; 33(3):238-43. PubMed ID: 12931325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction: metabolic and functional imaging in radiation therapy.
    Balter J
    Semin Radiat Oncol; 2011 Apr; 21(2):79. PubMed ID: 21356475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.